Terms: = Sarcomas AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
5 results:
1. PD1/pdl1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors.
Chen H; Liu H; Ai J; Du X; Sun Y; Xiao S
Clin Transl Oncol; 2022 Mar; 24(3):586-596. PubMed ID: 34741725
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Value of KRAS Mutation Subtypes and pd-l1 Expression in Patients With Lung Adenocarcinoma.
Tao L; Miao R; Mekhail T; Sun J; Meng L; Fang C; Guan J; Jain A; Du Y; Allen A; Rzeszutko BL; Socinski MA; Chang CC
Clin Lung Cancer; 2021 Jul; 22(4):e506-e511. PubMed ID: 32807653
[TBL] [Abstract] [Full Text] [Related]
3. Stabilization of Metastatic Uterine Leiomyosarcoma Using Pembrolizumab.
Cotangco K; Meram M; Lowe MP
J Natl Compr Canc Netw; 2020 Aug; 18(8):1012-1014. PubMed ID: 32755974
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic Correlation of Kaposi Sarcoma Involving the Ocular Adnexa: Immunophenotyping of Diagnostic and Therapeutic Targets.
Ulloa-Padilla JP; Ghassibi MP; Dubovy SR; Kerr DA
Ophthalmic Plast Reconstr Surg; 2020; 36(2):185-190. PubMed ID: 31743287
[TBL] [Abstract] [Full Text] [Related]
5. Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and pd-l1/PD-L2 expression and literature review.
May JM; Waddle MR; Miller DH; Stross WC; Kaleem TA; May BC; Miller RC; Jiang L; Strong GW; Trifiletti DM; Chaichana KL; Reimer R; Tun HW; Peterson JL
Radiat Oncol; 2018 Sep; 13(1):167. PubMed ID: 30185195
[TBL] [Abstract] [Full Text] [Related]